Answers are grounded in this paper and cite their sources.
Wound healing is the complex and dynamic tissue response to injury. It is an ordered and elegant process involving four phases, including hemostasis, inflammation, proliferation, and remodeling, which is controlled by an intricate array of growth factors and cytokines. New work focused on the manipulation of these factors provides the prospect for improvement and more effective management of acute and chronic wounds. Diabetic foot ulcers and venous stasis ulcers are frequently encountered wounds with high cost to the patient and society. Recent focus on more effective wound-healing treatments, including skin substitutes and hyperbaric oxygen, may lead to enhanced outcomes. Abbreviations:CSF colony stimulating factor, EGF epidermal growth factor, FGF fibroblast growth factor, GM-CSF granulocyte macrophage-colony-stimulating factor, MMP metalloproteinase, MPFF micronized purified flavonoid fraction, PDGF platelet-derived growth factor, TGF-β transforming growth factor-beta, TIMP tissue inhibitors of metalloproteinase, TxA2 thromboxane A2 Wound healing is an ordered process marked by four phases (Table 1). The first phase in physiologic wound healing is hemostasis. After disruption of tissue blood vessels, the coagulation cascade ensues through intrinsic and extrinsic pathways. The resultant product of either pathway is thrombin, which catalyzes the conversion of fibrinogen to fibrin. Fibrin forms a matrix, effectively trapping and binding platelets. The aggregated platelets secrete various mediators of wound healing, including the glycoprotein fibronectin, facilitating further cellular attachment, clot formation, and hemostasis. This scaffold also acts to release and trap numerous vasoactive and chemotactic factors important to later stages of wound healing [1].Table 1: Table 1. Stages of wound healingCSF, colony stimulating factor; EGF, epidermal growth factor; FGF, fibroblast growth factor; IL-1, interleukin-1; KGF, keratinocyte growth factor; MMP, metalloproteinase; PDGF, platelet-derived growth factor; TGF-β, transforming growth factor-beta; TIMP, tissue inhibitors of metalloproteinase; TNF-α, tumor necrosis factor-alpha; TxA2, thromboxane A2; VEGF, vascular endothelial growth factor.The second phase is inflammation. This phase involves a vasomotor-vasopermeability response with increased vasodilation and vascular permeability as well as the leukocyte infiltrate response with rapid influx of neutrophils and macrophages. Early cleansing of the wound by neutrophil-released oxygen-free radicals and lysosomal enzymes facilitates removal of bacteria and foreign debris. This phase is also marked by release of multiple growth factors and cytokines, including transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), interleukin-1, epidermal growth factor (EGF), prostaglandins, thromboxane, tumor necrosis factor alpha, and colony stimulating factor (CSF). Macrophages are an important source of these factors, and the absence or inadequacy of this cell type results in significantly impaired wound healing [2,3,4••]. The third phase is marked by proliferation and fibroplasia involving matrix production, angiogenesis, and epithelization. Gradually, leukocytes are replaced by macrophages and fibroblasts under the direction of FGF, PDGF, and TGF-β. Macrophage-directed cellular migration and proliferation begin to give the wound matrix its form while these cells also continue to modulate the immune response with antimicrobial action. Decreased oxygen tension and low pH stimulate angiogenic sprouting through endothelial cell migration. FGF-2 is the most potent cytokine stimulant to angiogenesis and appears to work in conjunction with a long list of factors, including various collagenase and vascular endothelial growth factor (Table 2). Epithelization also occurs during this phase. This process involves migration of keratinocytes from surrounding epithelium across the wound surface. The basement membrane slowly follows the leading edge of cells until complete closure of the epidermal layer. Several growth factors are involved in this stage, notably keratinocyte growth factor, TGF-β, FGF, EGF, and PDGF. Final epidermal function and appearance differ from those of normal epidermis [2,3,4••].Table 2: Table 2. Growth factors affecting wound healingEGF, epidermal growth factor; FGF, fibroblast growth factor; GM-CSF, granulocyte macrophage-colony-stimulating factor; IL-1, interleukin-1; KGF, keratinocyte growth factor; PDGF, platelet-derived growth factor; TGF-β, transforming growth factor β; VEGF, vascular endothelial growth factor.Remodeling is the final stage of wound healing. This stage begins as the wound matures and the concentration of fibroblasts within the matrix increases. Collagen formation by fibroblasts under the primary stimulation of TGF-β and PDGF gives the wound its strength and integrity. Type I makes up 80% to 90% of skin collagen with type III making up the remaining 10% to 20%. The fine control of wound remodeling is attributable to complex interactions between metalloproteinase (MMP) and growth factors. MMPs, composed of collagenase and gelatinase, are controlled in part by tissue inhibitors of metalloproteinase (TIMP). Turnover of extracellular matrix and collagen continues with increases in collagen cross-linking and decreases in the quantity of water and glycosaminoglycans. Ultimately, a balance is reached and a strong stable scar is formed, a process that can last up to 2 years [2,3,5].
No takes yet. Share an insight, caveat, or question.
Buerk et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: